Edward J. Rapp - Mar 31, 2024 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Edward J. Rapp
Stock symbol
ABBV
Transactions as of
Mar 31, 2024
Transactions value $
$38,605
Form type
4
Date filed
4/2/2024, 05:00 PM
Previous filing
Jan 17, 2024
Next filing
Apr 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Stock Equivalent Units Award $38.6K +212 +0.83% $182.10 25.7K Mar 31, 2024 Common Stock 212 $182.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.